Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis
ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of...
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-05-01
|
Series: | RMD Open |
Online Access: | https://rmdopen.bmj.com/content/6/1/e000928.full |
id |
doaj-e4a7db4415da402e9d3f6ba9d19c5429 |
---|---|
record_format |
Article |
spelling |
doaj-e4a7db4415da402e9d3f6ba9d19c54292020-12-14T14:47:39ZengBMJ Publishing GroupRMD Open2056-59332020-05-016110.1136/rmdopen-2019-000928Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritisPeter Nash0Ana-Maria OrbaiTore K Kvien1Dafna GladmanChen-Yen LinHitoshi GotoJulie A BirtSchool of Medicine, Griffith University, Brisbane, QLD, Australia 22 Rheumatology, Diakonhjemmet Hospital, Oslo, Norway ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of patients with psoriatic arthritis (PsA), the fatigue NRS was evaluated for test–retest reliability, construct validity and responsiveness. A responder definition was also explored using anchor-based and distribution-based methods.ResultsTest–retest reliability analyses supported the reproducibility of the fatigue NRS in patients with PsA (intraclass correlation coefficient=0.829). Mean (SD) values at baseline and week 2 were 5.7 (2.2) and 5.7 (2.4), respectively. Supporting construct validity of the fatigue NRS, moderate-to-large correlations with other assessments measuring similar concepts as measured by Sackett’s conventions were demonstrated. Fatigue severity was reduced when the underlying disease activity was improved and reductions remained consistent at week 12 and 24. A 3-point improvement was identified as being optimal for demonstrating a level of clinically meaningful improvement in fatigue NRS after 12–24 weeks of treatment.ConclusionsFatigue NRS is a valid and responsive patient-reported outcome instrument for use in patients with PsA. The established psychometric properties from this study support the use of fatigue NRS in clinical trials and in routine clinical practice. Robust validation of reliability for use in routine clinical practice in treating patients with active PsA in less active disease states and other more diverse ethnic groups is needed.https://rmdopen.bmj.com/content/6/1/e000928.full |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Peter Nash Ana-Maria Orbai Tore K Kvien Dafna Gladman Chen-Yen Lin Hitoshi Goto Julie A Birt |
spellingShingle |
Peter Nash Ana-Maria Orbai Tore K Kvien Dafna Gladman Chen-Yen Lin Hitoshi Goto Julie A Birt Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis RMD Open |
author_facet |
Peter Nash Ana-Maria Orbai Tore K Kvien Dafna Gladman Chen-Yen Lin Hitoshi Goto Julie A Birt |
author_sort |
Peter Nash |
title |
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
title_short |
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
title_full |
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
title_fullStr |
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
title_full_unstemmed |
Fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
title_sort |
fatigue numeric rating scale validity, discrimination and responder definition in patients with psoriatic arthritis |
publisher |
BMJ Publishing Group |
series |
RMD Open |
issn |
2056-5933 |
publishDate |
2020-05-01 |
description |
ObjectivesThis study assessed the psychometric properties of the fatigue numeric rating scale (NRS) and sought to establish values for clinically meaningful change (responder definition).MethodsUsing disease-specific clinician-reported and patient-reported data from two randomised clinical trials of patients with psoriatic arthritis (PsA), the fatigue NRS was evaluated for test–retest reliability, construct validity and responsiveness. A responder definition was also explored using anchor-based and distribution-based methods.ResultsTest–retest reliability analyses supported the reproducibility of the fatigue NRS in patients with PsA (intraclass correlation coefficient=0.829). Mean (SD) values at baseline and week 2 were 5.7 (2.2) and 5.7 (2.4), respectively. Supporting construct validity of the fatigue NRS, moderate-to-large correlations with other assessments measuring similar concepts as measured by Sackett’s conventions were demonstrated. Fatigue severity was reduced when the underlying disease activity was improved and reductions remained consistent at week 12 and 24. A 3-point improvement was identified as being optimal for demonstrating a level of clinically meaningful improvement in fatigue NRS after 12–24 weeks of treatment.ConclusionsFatigue NRS is a valid and responsive patient-reported outcome instrument for use in patients with PsA. The established psychometric properties from this study support the use of fatigue NRS in clinical trials and in routine clinical practice. Robust validation of reliability for use in routine clinical practice in treating patients with active PsA in less active disease states and other more diverse ethnic groups is needed. |
url |
https://rmdopen.bmj.com/content/6/1/e000928.full |
work_keys_str_mv |
AT peternash fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT anamariaorbai fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT torekkvien fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT dafnagladman fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT chenyenlin fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT hitoshigoto fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis AT julieabirt fatiguenumericratingscalevaliditydiscriminationandresponderdefinitioninpatientswithpsoriaticarthritis |
_version_ |
1724383639889772544 |